Performance Enhancing Drugs Market, By Drug Type (Anabolic Steroids (e.g., Testosterone, Nandrolone), Stimulants (e.g., Amphetamines, Caffeine, Ephedrine), Erythropoietin (EPO) and Blood Boosters, Human Growth Hormone (HGH) and Peptides, Selective Androgen Receptor Modulators (SARMs), Beta-Blockers , Diuretics , Nootropics (Cognitive Enhancers), and Others (e.g.,Insulin-like Growth Factor)), By Application (Athletic Performance, Cognitive Enhancement (Students, Professionals), Bodybuilding and Muscle Enhancement, Military and Defense, Recreational Use, Anti-Aging and Wellness , Weight Loss and Management, and Others (Injury Recovery and Rehabilitation)), By Route of Administration (Oral, Parenteral, Topical, and Others (Transdermal)), By Dosage Form (Pills/supplements, Injections, Patches, Oral Liquids, Others (Topical Creams)), By Gender (Male and Female), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Gyms and Sports Clubs, and Hospitals and Clinics), By End User (Professional Athletes, Bodybuilders and Fitness Enthusiasts, Students and Working Professionals, Military Personnel, and Others (Recretional Users)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)